Clinical Trials Browser

Adenocarcinoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial

Clinical Trials

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

IGASSU

IMCODE003

Fezo-ADT

A Study of Tucatinib and Trastuzumab in People With Rectal Cancer

ROWAN

Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer

DG-03

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer

Camrelizumab Combined With or Without Apatinib and SOX of Neoadjuvant Treatment for Gastric Cancer

Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer

Ph2 Study of Savolitinib and Durvalumab (MEDI4736) Combination in Advanced MET Amplified Gastric Cancer(VIKTORY-2)

BEMAFLOT

THIO Sequenced With Cemiplimab in Advanced NSCLC

REDI-CaP

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium

Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer

CONVERT-HB1

GRACIE

Cabozantinib and Pembrolizumab in Metastatic Pancreas

ARION

TALENT

Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) Trial

DisTinGuish

Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC)

A Study of MORAb-202 in Participants With Previously Treated Metastatic Non-Small Cell Lung Cancer (NSCLC) Adenocarcinoma (AC)

A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)

Boost GVAX Pancreas Vaccine With or Without CY in Patients With Pancreas Cancer

An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma

SEQUEL

A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer

MEMENTO

NOAHS-ARC

OLYMPIAN

CABATEN

Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma

NeoRacing

Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma

National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer

Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease

A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages

Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer

Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology

Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis

DG-06

Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas

Androgen Deprivation Therapy in Advanced Salivary Gland Cancer